International Isotopes Inc. Transitions to Radnostix, Inc.: A New Era in Radioisotope Innovation
Company Name Change and Rebranding
On December 31, 2025, International Isotopes Inc. (OTCQB: INIS) announced a significant transformation by officially changing its name to Radnostix, Inc. This change reflects the company’s evolution and its commitment to expanding its mission within the radioisotope and theranostics sectors. As it embarks on this journey under the new name, Radnostix aims to rebrand all operations, signaling a fresh chapter in its long-standing history.
History of International Isotopes Inc.
Founded in 1995, International Isotopes Inc. initially carved its niche focusing on the irradiation and manufacturing of industrial radioisotope products. Over the years, the company has broadened its vision and capabilities, leading to a strategic focus on innovative solutions in radioisotopes and theranostics. The name change encapsulates this evolution, allowing the company to present a unified brand that resonates with its next-generation product offerings.
Continuity Amidst Change
While the name International Isotopes Inc. will no longer be the flagship, the established INIS branding will continue to be utilized for specific segments concentrated on high energy sources, bulk radioisotopes, and stable isotopes. Other existing brands, such as Radqual, Radvent, Easyfill, Benchmark, and PhanQual, will continue to thrive under the Radnostix umbrella. This strategic decision ensures that the company’s operations, management team, and commitment to excellence in customer service remain intact.
Leadership Vision
Shahe Bagerdjian, the CEO of Radnostix, articulated the company’s future vision: “The name Radnostix better encapsulates our mission to become the premiere industry partner in the radioisotope & theranostics space.” Bagerdjian emphasized that despite the rebranding, the company’s dedication to quality, innovation, and superior customer service would remain paramount. This leadership vision paves the way for enhanced collaboration and growth within the specialized field of radioisotopes.
Impact on Stockholders
As part of the name change, Radnostix has reassured its shareholders that the company’s common stock will continue to trade under its current ticker symbol “INIS” on the OTCQB marketplace. There are no immediate actions required from shareholders concerning their stock certificates, a move designed to provide stability during this transition period. Further announcements regarding any potential new ticker symbol will be made as developments arise.
The Future of Radnostix
The rebranding to Radnostix, Inc. marks a pivotal moment for the company as it aims to enhance its position in the industry. Established in Idaho Falls, Idaho, Radnostix is dedicated to manufacturing a wide range of products centered around radioisotopes. This includes generic sodium iodide I-131, a critical pharmaceutical drug product for treating hyperthyroidism and thyroid cancer, as well as offering contract manufacturing services for various drug products and radioisotope active pharmaceutical ingredients for third-party theranostics clients.
The transition also extends to the company’s calibration and reference standards. Under the RadQual brand, Radnostix will continue to provide comprehensive solutions for nuclear pharmacies and SPECT/PET imaging systems alongside industrial calibration standards.
Commitment to Innovation and Quality
Radnostix is poised to not only maintain but enhance its commitment to quality and innovation in the radioisotope and theranostics landscape. As the company continues to navigate its rebranding journey, it emphasizes its steadfast strategic direction, aiming for comprehensive growth in a rapidly evolving marketplace.
Safe Harbor Statement
Radnostix’s recent announcements also included a safe harbor statement, a standard protocol for public companies. It highlights the forward-looking nature of the company’s communications and the inherent risks involved, encouraging investors to review the company’s filings with the Securities and Exchange Commission for detailed insights.
Contact Information
For those interested in learning more about Radnostix, the company has made its contact details easily accessible. Investors and stakeholders can reach out through the provided emails or visit the official websites for comprehensive information and updates.
As Radnostix, Inc. takes its next strides in the radioisotope industry, its commitment to transparency, innovation, and customer satisfaction continues to guide its operations and strategic direction.